Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Statistical Results Show the Timeliness and Effectiveness of China's Measures against COVID-19


News provided by

Science and Technology Daily

30 Apr, 2020, 15:28 GMT

Share this article

Share toX

Share this article

Share toX

BEIJING, April 30, 2020 /PRNewswire/ -- A news report by Chen Chao and Long Yun from Science and Technology Daily:

"COVID-19 is the biggest crisis the world has faced since World War 2," Mr. Zhou Weisheng, a Professor from College of Policy Science, Ritsumeikan University said in an interview with Science and Technology Daily.

Continue Reading
This image opens in the lightbox
Mr. Zhou Weisheng, a Professor from College of Policy Science, Ritsumeikan University

Dr. Zhou believes that the spread of COVID-19 further proves that we live a community of shared future for mankind with common benefits and risks. In order to achieve the goal of maximizing the benefits and minimizing the risks, international cooperation and mutual support are required in both prevention and control of the pandemic and the protection of the global industrial chain.

China's experience has raised alerts from two aspects for the world  

Zhou said that since the outbreak of COVID-19, the efforts and spirit of the Chinese people, such as the spirit of self-sacrifice, perspective of overall situation and coordinated actions, have shown the strength of the Chinese people with solidarity, and won a great amount of time for the world to contain the spread of the COVID-19.

At the same time, Dr. Zhou noted, China has raised alerts from two aspects for the world from the statistical results.

First, during the battle against COVID-19, China obtained the first-hand pathological data, which made the world well-informed about the fact that COVID-19 was spreading around the world extremely quickly; Second, China had to take the strictest measures to prevent and control the situation through city lockdown, which has alarmed the world by these bold measures.

China has won the world time to combat COVID-19 with first-hand experience

Viruses know no national borders, and many countries had experienced infectious disasters in the past. Dr. Zhou also emphasized that China has made contribution to the world.

The first one is to gain time for the world to prepare for dealing with COVID-19. Zhou Weisheng's lab is carrying out research on the policy initiatives of various countries since the beginning of the epidemic. His research team aims to sum up experience and lessons through quantitative analysis for better prevention in the future.

Zhou made a detailed introduction on the results of his research that there are two Modes of outbreak. Mode A (Area A) is the Cruise Ship Mode (such as Diamond Princess cruise ship, which refers to the rapid outbreak of infection in areas with high population density). And Mode B (Area B) is the Urban Mode (Wuhan in China, Italy, etc.). From the statistical analysis, in Mode A, the incubation period from the detection of the first infected case to the outbreak of infection is about 7 days. When it comes to Mode B, the incubation period from the detection of the first infected case to the outbreak of infection is about 30 days. That is to say, it is extremely important to take decisive measures within one month after the discovery of the first infected case.

According to the World Health Organization's timeline against COVID-19, on December 31, 2019, Wuhan Municipal Health Commission in China reported a cluster of pneumonia cases in Wuhan, Hubei Province. A novel coronavirus was eventually identified. And on January 23, 2020, China took a series of decisive prevention and control measures, which marked by Wuhan lockdown. In the face of this previously unknown pandemic, China has tried its best to fight against COVID-19 without any delay.

Wu Zunyou, chief epidemiologist at the Chinese Center for Disease Control and Prevention, noted that China reported information to the World Health Organization regarding the outbreak (January 3). In the same day, China began to inform the United States about the pneumonia of unknown cause. Starting from January 3, China has been regularly informing the WHO, relevant countries and regions about the pneumonia of unknown cause. On January 12, China shared the genome sequences of the novel coronavirus with WHO and other countries in a timely manner, Wu also said.

In response to COVID-19, China has promptly released relevant information, shared experience and promoted international cooperation in an open, transparent and responsible manner.

Sino-US cooperation is the 'best option' for all

In that urgent scenario, China had no previous experience to draw on and had to take prevention and control measures with careful trials. However, some countries could take measures in their own way while referring to China's experience.

US now has most COVID-19 cases in the world, with more than one million confirmed cases.

"As the world's largest developed country, the United States should have guided and supported the world in the effective prevention and control on the basis of China's experience. Some countries have underestimated the importance of China's experience in preventing the spread of novel coronavirus," Dr. Zhou said.

He sincerely hopes that China and the United States could not only fight against COVID-19 for their own people, but also work together to lead the world, especially developing countries, out of difficulties and overcome the catastrophic challenge.

"Determining the origin and route of the infection of novel coronavirus requires scientific and objective research. The region where the infection information was firstly publicly disclosed is not necessarily the origin of the novel coronavirus. Because it is possible that other affected areas have not been announced or the patients in these areas have been treated for other diseases such as influenza. Searching the origin of novel coronavirus should be supported by solid scientific evidence and intensive research. Every country in the world shares the same responsibility," Dr. Zhou Weisheng emphasized in the end.

Photo - https://mma.prnewswire.com/media/1162315/Zhou_Professor.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.